Agilent Technologies Inc. (Santa Clara, California) and Seahorse Bioscience (Billerica, Massachusetts) have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a provider of instruments and assay kits for measuring cell metabolism and bioenergetics.

Seahorse Bioscience’s technology enables researchers to better understand cell health, function, and signaling, and how the cell may be impacted by the introduction of a specific drug, by providing real-time kinetics to unlock essential bioenergetics data.